Explore the vast range of titles available.

Introduction Prolonged activated partial thromboplastin time (aPTT) in plasma samples requires quick and accurate differential diagnosis. We developed two methods using clot waveform analysis (CWA) for plasma samples with prolonged aPTT, particularly for factor (F)VIII deficiency. One method estimates FVIII activity (FVIII:C) using CWA without measuring FVIII:C by template matching. The other utilizes CWA in the mixing test to quickly differentiate FVIII deficiency (FD), FVIII inhibitor (Inh), and lupus anticoagulant (LA). Aim To establish a more accurate system for differential diagnosis of aPTT prolongation, including FIX deficiency, by combining a CWA-based mixing test and template matching. Methods Samples with FD ( n  = 96), LA ( n  = 19), and Inh ( n  = 28) were incubated with normal plasma. FD, LA, and Inh were differentiated using a mixing test, followed by CWA-based template matching. Results In the mixing test, sensitivity for FD, Inh, and LA was 100%, 93%, and 100%, and specificity was 96%, 100%, and 100%. Samples with FIX inhibitor (> 0.6 BU/mL) were differentiated as the inhibitor sample. In template matching, almost all severe hemophilia A and B were judged as the respective severe types. Conclusion This novel CWA-based measurement system could aid in differential diagnosis of prolonged aPTT.

To address the challenges of slow curing speed and suboptimal microwave absorption during the paving of cold-mixed and cold-laid asphalt mixtures, this study introduces SiC-Fe3O4 composite material (SF) into emulsified asphalt mixtures to enhance microwave absorption and accelerate curing via microwave heating. Initially, based on the maximum density curve theory, an appropriate mineral aggregate gradation was designed, and the optimal ratio of emulsified asphalt mixture was determined through mixing tests, cohesion tests, wet wheel wear tests, and load wheel sand adhesion tests. Subsequently, the influence of SF content on the mixing performance of emulsified asphalt mixtures was analyzed through mixing and consistency tests. Finally, the microwave absorption performance of the mixture was evaluated by designing microwave heating tests under different conditions, using temperature indicators and quality indicators. The experimental results indicate that when SF content ranges from 0% to 4%, the mixing performance of the emulsified asphalt mixture meets specification requirements. The dosage of SF, SF composite ratio, and microwave power significantly impact microwave absorption performance, whereas environmental temperature has a relatively minor effect. The optimal mix ratio for the emulsified asphalt mixture is mineral aggregate:modified emulsified asphalt:water:cement = 100:12.8:6:1. The ideal SF dosage is 4%, with an optimal SiC to Fe3O4 composite ratio of 1:1, and a suitable microwave power range of 600–1000 W.

The use of construction waste to prepare recycled micro powder can improve the use of construction waste resources and effectively reduce carbon emissions. In this paper, researchers used waste concrete processing micro powder to prepare foam concrete (FC) and quantitatively characterized the performance and pore structure of FC by scanning electron microscopy (SEM), pore and fissure image recognition and analysis system (PCAS), and mechanical property testing methods with different mixing ratios of micro powder. The results showed that the effect of single mixing of micro powder or fly ash is better than the composite mixing test, and the optimal proportion of compressive strength of single mixing of micro powder is higher than that of single mixing of fly ash. The optimum mixing ratio is 6:4 between cement and micro powder, and the best effect is achieved when the micro powder mixing amount is 40%. Single or double mixing can fill the pores between the foam and strengthen the performance of the substrate. The tests of single-mixed or compound-mixed micro powder showed that the fractal dimension decreased with the increase of porosity; when the fractal dimension of the specimen increased, the average shape factor became smaller, the compressive strength decreased, and the water absorption rate increased. Keywords: fractal dimension; porosity; recycled micro powder.

In structures manufactured using 3D concrete printing, cracks can easily propagate along the interface between printed layers. Therefore, it was necessary to determine the interlayer bond strength. In this study, direct shear and tensile tests were performed to determine the interlayer bond stability of the 3DCP members. To confirm the appropriateness of the mix proportion used to fabricate the specimens, the open time available for printing was identified via a mixing test, and the extrudability and buildability were verified via a printing test. In addition, direct shear and tensile tests were performed using the specimen manufacturing method (i.e., mold casting and 3D printing) and printing time gap (PTG) between the laminated layers as key test variables. The interlayer bond strengths of the specimens, according to the variables obtained from the test results, were compared and analyzed based on the interfacial shear strength standards presented in the current structural codes. In the direct shear test, failure occurred at the interlayers of all the specimens, and the interlayer bond strength tended to decrease with increasing PTG. In addition, the interlayer bond strength of the direct shear specimens exceeded the interfacial shear strength suggested by current structural codes. In contrast, in the direct tensile test, interlayer surface failure occurred only in some specimens, and there was no distinct change in the interlayer bond strength owing to PTG.

Deep bed sandfilters (DBS) are a potential alternative to high efficiency particulate airfilters (HEPA), especially for large nuclearfacilities where long-term mission performance andfire/explosion resistance are required. The performance of DBS filters must be established through air-aerosol mixing and leakage tests, which require aerosol sampling at several predetermined sampling locations. Given the specified aerosol concentration distribution and repeatability according to relevant standards, reliable aerosol sampling probes are essential. In this study, isokinetic and shrouded sampling probes are modeled using computational fluid dynamics to analyze their applicability for DBS performance verification tests. An axisymmetric two-dimensional geometry is adopted, considering the horizontal installation of the probes. Anisotropic turbulence models, discrete phase models, continuity equations, and momentum equations are solved simultaneously for aerosol tracking. The discrepancies and agreements between the simulation results and available test data are discussed. The influence of operating conditions such as free-stream velocity, particle diameter, particle density, and sampling flow rate is analyzed in terms of the actual probe readout parameter, the transmission ratio. Modeling strategies for turbulence intensity and turbulent particle dispersion are also discussed. To understand the behavior of the samplers, the geometric effects of the probes are analyzed by varying the probe geometries. Finally, the limitations of computationalfluid dynamics are presented.

Microfluidic technologies have enormous potential to offer breakthrough solutions across a wide range of applications. However, the rate of scale-up and commercialization of these technologies has lagged significantly behind promising breakthrough developments in the lab, due at least in part to the problems presented by transitioning from benchtop fabrication methods to mass-manufacturing. In this work, we develop and validate a method to create functional microfluidic prototype devices using 3D printed masters in an industrial-scale roll-to-roll continuous casting process. There were no significant difference in mixing performance between the roll-to-roll cast devices and the PDMS controls in fluidic mixing tests. Furthermore, the casting process provided information on the suitability of the prototype microfluidic patterns for scale-up. This work represents an important step in the realization of high-volume prototyping and manufacturing of microfluidic patterns for use across a broad range of applications.

We report a case of acquired hypofibrinogenemia with multiple myeloma presenting λ-type IgG monoclonal protein. The patient had anemia and renal deficiency, and also developed bleeding tendency due to severe coagulopathy. Her fibrinogen level was under the detectable limits in a functional assay. Enzyme-linked immunosorbent assay (ELISA) and immunoblotting analysis results were consistent with functional assay results, and deficiency patterns observed in cross-mixing tests for PT and aPTT confirmed the diagnosis of hypofibrinogenemia. To determine the cause of hypofibrinogenemia, we purified the patient’s immunoglobulin via protein A agarose, and confirmed that fibrinogen was included in the bound fraction, strongly indicating paraprotein interference with fibrinogen. As accelerated removal of fibrinogen was indicated, we incubated the patient’s plasma up to 48 h, but did not observe significant loss of fibrinogen. In sharp contrast, fibrinogen returned to below the detection level 12 h after infusion of fresh frozen plasma. These findings support leukocyte-mediated fibrinogen removal, rather than paraprotein-triggered fibrinogen instability. Surprisingly, the patient’s paraprotein was IgG2, but we speculate the amount of paraprotein (IgG 5346 mg/dL) compensated for lower affinity to Fcγ receptors.

Objective A high prevalence of antiphospholipid antibodies (aPL) has been reported in patients with coronavirus disease 2019 (COVID-19). Although some studies have demonstrated roles for aPL in thrombotic events in COVID-19, findings on their association with disease development and outcomes remain heterogeneous. Therefore, this study investigated whether aPL may serve as effective markers for determining the development and outcome of COVID-19. Methods Serum samples were isolated from whole blood of 95 individuals with moderate and severe COVID-19. The prevalence of lupus anticoagulant (LA), IgM/IgG antiphospholipid (aPL), IgM/IgG anti-β2-glycoprotein I (aβ2GPI), and IgM/IgG anticardiolipin (aCL) antibodies was measured by enzyme-linked immunosorbent assay. A mixing test was performed in patients with unexplained prolongation of activated partial thromboplastin time (aPTT) to distinguish coagulation factor deficiencies from factor inhibitors. The percentage of selected immune cells and values of biochemical markers were also assessed. Results Patients with severe COVID-19 showed significant increases in IgG aβ2GPI and IgG aPL antibody levels compared with individuals with moderate COVID-19 ( P  < 0.05). The mixing test showed that LA had an increased prevalence in severe patients with unexplained prolongation of aPTT and prothrombin time (PT) ( P  < 0.01–0.05). No significant differences were observed in IgM/IgG aCL, IgM aPL, or IgM aβ2GPI antibody levels between severe and moderate cases. Additional findings revealed that severe COVID-19 patients who required intensive care unit (ICU) treatment had significant increases in IgM/IgG aPL, IgM/IgG aCL, and IgM/IgG aβ2GPI antibodies ( P  < 0.01–0.05). However, there was no significant change in the prevalence of LA or IgM aβ2GPI antibodies between severe patients who required ICU therapy and those who did not. IgM aCL and IgG aPL values were significantly higher in non-survivors compared with survivors ( P  < 0.001–0.05). A similar trend was observed for IgG aCL and IgM aPL levels in non-survivors, although these increases were not statistically significant. Conclusion Changes in aPL levels may be considered effective markers for clarifying the severity and outcome of COVID-19. Clinical trial Not applicable.

Autoimmune factor XIII (FXIII) deficiency (AiF13D) is a rare hemorrhagic disease. The anti-FXIII autoantibodies that cause this disease are classified into three types: type Aa inhibits the heterotetramer assembly and activation of FXIII, type Ab inhibits the enzymatic activity of activated FXIII, and type B enhances the elimination of FXIII from the blood. The former two are FXIII inhibitors and may be lethal if overlooked by conventional functional assays. To reliably detect both types of FXIII inhibitors, a new assay was developed by incorporating 5-(biotinamido)pentylamine (BAPA) into α 2 -plasmin inhibitor (PI-BAPA assay). This assay was tested on plasma samples from 128 participants, including 60 healthy controls, 35 patients with non-immune acquired FXIII deficiency, and 33 patients with AiF13D (29 with type Aa inhibitors and 4 with type Ab inhibitors). The PI-BAPA assay successfully detected type Aa and Ab inhibitors in 5-step dilution cross-mixing tests between patient and normal plasma. This assay also showed comparable or superior inhibition rates in the 1:1 mixing test compared to conventional ammonia release and amine incorporation assays. Receiver operating characteristic curve analysis confirmed the excellent specificity and sensitivity of this assay for determining inhibition rates, and the assay has already been used for AiF13D diagnosis.

Activated partial thromboplastin time (aPTT) is a fundamental screening test for coagulation disturbances. An increased aPTT ratio is quite common in clinical practice. How the detection of prolonged activated aPTT with a normal prothrombin time is interpreted is therefore very important. In daily practice, the detection of this abnormality often leads to delayed surgery and emotional stress for patients and their families and may be associated with increased costs due to re-testing and coagulation factor assessment. An isolated, prolonged aPTT is seen in (a) patients with congenital or acquired deficiencies of specific coagulation factors, (b) patients receiving treatment with anticoagulants, mainly heparin, and (c) individuals/patients with circulating anticoagulants. We summarize here what may cause an isolated prolonged aPTT and evaluate the preanalytical interferences. The identification of the cause of an isolated prolonged aPTT is of the utmost importance in ensuring the correct diagnostic workup and therapeutic choices.